spacer
home > pmps > winter 2017 > tools of the trade
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Tools of the Trade

Increasing production without the investment in new machinery or operators is the preferred approach when formulating tablets, and one way to do this successfully is through the use of multi-tipped tooling. This method comes with numerous benefits, the most obvious being improved productivity owing to the greater number of tablets per turret rotation. It also offers a reduction in the run time per batch and campaign, resulting in less maintenance overall and a shorter press downtime. Furthermore, there is no capital outlay on new tablet presses and, as fewer presses are required to satisfy production levels, less floor space is needed, leading to the production of more tablets per square metre – a significant advantage for today’s modern medicine manufacture.

Production Benefits

Simply put, multi-tipped toolings are punches that have more than one tip – ranging from a simple 2 tip punch to one with 40 tips per punch. This number can, however, be increased depending on the size and design of a particular product. By successfully implementing multitipped tooling, the amount of tool set-ups required per production batch can also be reduced and batches are completed more quickly, cutting the overall time necessary to make the tablets.

This leads to further benefits, from the decrease in energy consumption due to the press running for shorter periods of time, to the reduction in man hours required per press. The cost to maintain the machine is also diminished while overall press availability will be increased, thereby making time for additional production. If a tablet requires a short compression time from when a formulation is prepared, multi-tips offer a distinct advantage over single tip production as the process can be completed faster and within optimum conditions.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Holding the role of Product Design Manager since 2004, Steve Osborn is I Holland’s leading design and multitipped tooling expert. He is a key member of the Customer Support Group, and is also responsible for the manufacturing functions of hob make/hobbing and heat treatment. Steve has appeared several times in the company’s knowledge sharing series of webinars and as a guest speaker at other industry events.
spacer
Steve Osborn
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics receives Queen’s Award for Enterprise

Cambridge, UK, 21 April 2020: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, has be honored with a Queen’s Award for Enterprise for Innovation. The award recognizes the Company’s excellence in patenting, developing and globally commercializing single cell analysis systems for biotherapeutic discovery.
More info >>

White Papers

Biosimilars In Emerging Markets: Is It A Level Playing Field?

PRA Health Sciences (PRA)

Governments, healthcare payers, and social and health reforms, combined with the increased incidence of conditions such as cancer and diabetes are paving the way for increased uptake of biologic medicines in emerging markets. However, expensive biologic medicines can be prohibitive to many patients, creating a high level of unmet clinical need. At its best, the global expansion of biosimilars can mean a robust and steady supply of existing and new drugs reaching far-flung patient populations, but localized biosimilar drug developments, especially in China and India, combined with a lack of robust pharmacovigilance systems, threaten to derail the industry by putting patient health at risk.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement